Search

everythinglearnresearchcommunity

for

Search:↓

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

Combining UVB irradiation and anti-CD154 antibody improves hair follicle transplant survival.

A botanical extract may help manage hair loss from chemotherapy by preventing cell death in hair follicles.

Systemic corticosteroids can help treat rapidly spreading vitiligo but require more research for safer use.

Fibroblast Growth Factors (FGFs) are important for tissue repair and regeneration, influencing cell behavior and other factors involved in healing, and are crucial in processes like wound healing, bone repair, and hair growth.

Hair can regrow in large wounds through a process similar to how hair forms in embryos, and understanding this could lead to new treatments for hair loss or scarring.

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

New medicines that block a specific pathway are showing promise for treating severe hair loss but need more testing for safety and effectiveness.

Alopecia areata involves complex immune and genetic factors, with potential treatment targets identified, but more research is needed.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.

Minoxidil can cause a skin reaction called ALEP.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

Thymoma-associated multiorgan autoimmunity can cause liver damage and affects multiple organs, with limited treatment options and a generally poor prognosis.

A teenager had both alopecia areata and vitiligo, which are rare to occur together.

JAK inhibitors may help treat alopecia areata by reversing hair loss.

The document concludes that Borrelia afzelii causes a skin condition in France, a gene is linked to hair loss in Caucasian women, and various genetic mutations affect skin diseases.

Stem cell research and regenerative medicine have made significant advancements in treating various diseases and conditions.

Both induced and spontaneous AA lymphocytes can cause alopecia areata in mice.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

The Foxn1 gene mutation causes hairlessness and immune system issues, and understanding it could lead to hair growth disorder treatments.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Hair follicles can help wounds heal faster and this knowledge could be used to treat chronic skin ulcers, with a potential use of a special stem cell hydrogel to enhance healing.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Sebaceous glands play a key role in skin health, immunity, and various skin diseases.

Skin abnormalities can indicate immunodeficiency due to shared origins with the immune system.

A patient with Crohn's disease grew back their hair after stopping Adalimumab, which had caused hair loss.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.